HUT44042A - Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides - Google Patents

Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides

Info

Publication number
HUT44042A
HUT44042A HU871056A HU105687A HUT44042A HU T44042 A HUT44042 A HU T44042A HU 871056 A HU871056 A HU 871056A HU 105687 A HU105687 A HU 105687A HU T44042 A HUT44042 A HU T44042A
Authority
HU
Hungary
Prior art keywords
renin inhibitor
inhibitor peptides
pharmaceuticals
amino acid
well
Prior art date
Application number
HU871056A
Other languages
English (en)
Inventor
Wolfgang Bender
Rolf Henning
Andreas Knorr
Johannes-Peter Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUT44042A publication Critical patent/HUT44042A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU871056A 1986-03-12 1987-03-11 Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides HUT44042A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3608209 1986-03-12
DE19863628650 DE3628650A1 (de) 1986-03-12 1986-08-23 Renininhibitoren, verfahren zur herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
HUT44042A true HUT44042A (en) 1988-01-28

Family

ID=25841883

Family Applications (1)

Application Number Title Priority Date Filing Date
HU871056A HUT44042A (en) 1986-03-12 1987-03-11 Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides

Country Status (8)

Country Link
US (1) US4818748A (hu)
EP (1) EP0236874A3 (hu)
KR (1) KR870008915A (hu)
AU (1) AU600704B2 (hu)
DE (1) DE3628650A1 (hu)
DK (1) DK124787A (hu)
HU (1) HUT44042A (hu)
IL (1) IL81833A (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3711866A1 (de) * 1987-04-08 1988-10-27 Hoechst Ag Synthese von peptidamiden mittels festphasenmethode unter verwendung von saeurelabilen ankergruppen
EP0314239A3 (en) * 1987-10-28 1990-12-27 Merck & Co. Inc. Tripeptide renin inhibitors with n-terminal ureido or sulfamido groups
DE3743225A1 (de) * 1987-12-19 1989-06-29 Merck Patent Gmbh Verfahren zur herstellung von statinderivaten
IT1216104B (it) * 1988-03-16 1990-02-22 Zambon Spa Peptidi ad attivita' farmaceutica.
JPH03505875A (ja) * 1988-07-08 1991-12-19 スミスクライン・ベックマン・コーポレイション レトロウイルス・プロテアーゼ結合ペプチド
DE3902615A1 (de) * 1988-08-27 1990-03-08 Bayer Ag Aminomethyl-peptide, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5270302A (en) * 1988-12-21 1993-12-14 Abbott Laboratories Derivatives of tetrapeptides as CCK agonists
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
DE4035851A1 (de) * 1990-11-10 1992-05-14 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung
DE3936298A1 (de) * 1989-11-01 1991-05-02 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5464820A (en) * 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
AU759022B2 (en) * 1999-02-18 2003-04-03 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
EP1732531A2 (en) * 2004-02-25 2006-12-20 La Jolla Pharmaceutical Company Amines and amides for the treatment of diseases
ES2673873T3 (es) 2012-07-24 2018-06-26 Merck Patent Gmbh Derivados de hidroxiestatina para el tratamiento de la artrosis
AU2014280593B2 (en) * 2013-06-12 2018-11-08 Merck Patent Gmbh Hydroxy-ethylene derivatives for the treatment of arthrosis
CN104530038A (zh) * 2014-12-10 2015-04-22 沈阳药科大学 酰胺咪唑类衍生物及其用途
WO2017027967A1 (en) * 2015-08-17 2017-02-23 University Health Network Inhibitors of peptidyl arginine deiminase (pad) enzymes and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
EP0104041B1 (en) * 1982-09-15 1988-07-27 Aktiebolaget Hässle Enzyme inhibitors
US4668770A (en) * 1982-12-27 1987-05-26 Merck & Co., Inc. Renin inhibitory tripeptides
US4668663A (en) * 1984-03-27 1987-05-26 Merck & Co., Inc. Renin inhibitors containing homophe8
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres

Also Published As

Publication number Publication date
DE3628650A1 (de) 1987-09-24
AU600704B2 (en) 1990-08-23
EP0236874A3 (de) 1990-06-13
IL81833A0 (en) 1987-10-20
DK124787D0 (da) 1987-03-11
DK124787A (da) 1987-09-13
US4818748A (en) 1989-04-04
IL81833A (en) 1992-03-29
EP0236874A2 (de) 1987-09-16
AU7004087A (en) 1987-09-17
KR870008915A (ko) 1987-10-22

Similar Documents

Publication Publication Date Title
HUT44042A (en) Process for preparing renin inhibitor peptides, amino acid and aminoaldehyde derivatives, as well as pharmaceuticals comprising renin inhibitor peptides
ZA877950B (en) Amino acid derivatives
HU901261D0 (en) Process for preparation of amino acid derivatives
HUT47949A (en) Process for producing substituted alpha-amino acids, their derivatives and pharmaceuticals comprising these compounds
HUT44043A (en) Process for preparing new amino acid derivatives
ZA947296B (en) Process for preparing amino acid polymers
AU7004487A (en) Process for spray drying amino acid composition
ZA906766B (en) Process for cyclic amino acid anticonvulsant compounds
NZ224706A (en) Amino acid 1,2-diketo derivatives as renin inhibitors
CS316491A3 (en) Derivatives of amino acids, process of their preparation and pharmaceuticals based thereon
EP0231996A3 (en) Novel amino acid derivatives
YU146686A (en) Process for preparing derivatives of amino acids
HUT68774A (en) Heterocyclic iminobismethylenebisphosphonic acid derivatives, process for preparing them, and pharmaceutical preparations containing them
AU587426B2 (en) Peptide amino-alcohol derivatives inhibiting renin and acid proteases, process for preparation and application in therapy
IL88998A0 (en) Novel amino acid glycerides,processes for their preparation,and pharmaceutical compositions containing them
ZA875692B (en) Amino acid derivatives
PT73156A (en) Process for preparing n-(cycloalkyl)amino acid derivatives
HUT53663A (en) Process for producing amino acid derivatives
HUT47947A (en) Process for producing unsaturated amino acid compounds and pharmaceuticals comprising same as active ingredient
IL90031A0 (en) Amino acid esters,a process for the preparation thereof,pharmaceuticals containing them,and the use thereof
EP0239063A3 (en) Process for preparing n-omega-trifluoroacetyl amino acid
AR243865A1 (es) Procedimientos para fabricar derivados de aminoacidos; y silil derivados de aminoacidos utiles como intermediarios en dicho procedimiento.
GB8806571D0 (en) Supports for proteins & amino acids
ZA861439B (en) Peptide amino-alcohol derivatives inhibiting renin and acid proteases,process for preparation and application in therapy
DK400085A (da) Aminosyrederivater, fremgangsmaader til fremstilling heraf og laegemidler indeholdende saadanne derivater

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment